Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-25-058336
Filing Date
2025-06-11
Accepted
2025-06-11 06:04:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFR14A tm2517713d1_defr14a.htm DEFR14A 16423
2 GRAPHIC tm2517713d1_defr14aimg001.jpg GRAPHIC 30400
  Complete submission text file 0001104659-25-058336.txt   59586
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-40021 | Film No.: 251038709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)